Phytoestrogen Interaction with Estrogen Receptors in Human Breast Cancer Cells

Endocrinology

Volumn 103, Issue 5, 1978, Pages 1860-1867

  Martin, Pierre M ^a   Horwitz, Kathryn B ^b   Ryan, Dale S ^c   McGuire, William L ^b  

^a INSTITUT PAOLI CALMETTES   (France)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COUMESTROL; ESTROGEN RECEPTOR; FORMONONETIN; GENISTEIN; PHYTOESTROGEN; ZEARALENONE; ZERANOL;

BREAST; BREAST CANCER; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; ESTRADIOL H 3; HUMAN CELL; IN VITRO STUDY;

BREAST NEOPLASMS; CELL LINE; COUMARINS; COUMESTROL; FLAVONES; HUMAN; ISOFLAVONES; MYCOTOXINS; RECEPTORS, ESTROGEN; SEX HORMONE-BINDING GLOBULIN; SUPPORT, U.S. GOV'T, P.H.S.; ZEARALENONE; ZERANOL;

EID: 0018129082     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo-103-5-1860     Document Type: Article

References (41)

1. Farnsworth, N. R., A. S. Bingel, G. A. Cordell, F. A. Crane, and H. H. S. Forng, Potential value of plants as sources of new antifertility agents. I., J Pharm Sci 64: 535, 1975.
2. Farnsworth, N. R., A. S. Bingel, G. A. Cordell, F. A. Crane, and H. H. S. Forng, Potential value of plants as sources of new antifertility agents. II., J Pharm Sci 64: 717, 1975.
3. Braden, A. W. H., N. K. Hart, and J. A. Lamberton, Disorders of grazing animals due to plant constituents, In Moore, R. M. (ed.), Australian Grasslands, Canberra, Australia, 1970, p. 381.
4. Mellies, M., C. J. Glueck, C. Sweeney, R. W. Fallat, R. C. Tsand, and T. T. Ishikawa, Plasma and dietary phytosterols in children, Pediatrics 57: 60, 1976.
5. Rao, M. K. G., E. G. Perkins, W. E. Connor, and A. K. Bhattacharyya, Identification of B-sitosterol, com-pesterol and stigmasterol in human serum, Lipids 10: 566, 1975.
6. 3H]oestradiol by uterus, vagina, and skeletal muscle of immature mice, J Endocrinol 44: 213, 1969.
7. Shutt, D. A., Interaction of genistein with oestradiol in the reproductive tract of the ovariectomized mouse, J Endocrinol 37: 231, 1967.
8. Shemesh, M., H. R. Lindner, and N. Ayalon, Affinity of rabbit uterine oestradiol receptor for phytooestro-gens and its use in a competitive protein-binding radioassay for plasma coumestrol, J Reprod Fertil 29: 1, 1972.
9. Shutt, D. A., and R. I. Cox, Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro, J Endocrinol 52: 299, 1972.
10. Perel, E., and H. R. Linder, Dissociation of utero-trophic action from implantation-inducing activity in two non-steroidal oestrogens (coumestrol and genistein),' J Reprod Fertil 21: 171, 1970.
11. Leavitt, W. W., and D. M. Meismer, Sexual development altered by non-steroidal oestrogens, Nature 218: 181, 1968.
12. Anonymous, Diethylstilbestrol—order denying a hearing and withdrawing approval of new animal drug applications for diethylstilbestrol implants, Fed Reg 38: 10485, 1973.
13. Noble, R. L., and L. Hoover, A classification of transplantable tumors in Nb rats controlled by estrogen from dormancy to autonomy, Cancer Res 35: 2935, 1975.
14. Horwitz, K. B., and W. L. McGuire, Progesterone and progesterone receptors in experimental breast cancer, Cancer Res 37: 1722, 1977.
15. Leung, B. S., and G. H. Sasaki, On the mechanism of prolactin and estrogen action in 7, 12-dimethyl -benz(a)anthracene-induced mammary carcinoma in the rat. II. In vivo tumor responses and estrogen receptors, Endocrinology 97: 564, 1975.
16. Soule, H. D., J. Vasquez, A. Long, S. Albert, and M. Brennan, A human cell line from a pleural effusion derived from a breast carcinoma, J Natl Cancer Inst 51: 1409, 1973.
17. Horwitz, K. B., and W. L. McGuire, Estrogen control of progesterone receptors in breast cancer: correlation with nuclear processing of estrogen receptor, J Biol Chem 253: 2223, 1978.
18. Burton, K., A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid, Biochem J 62: 315, 1956.
19. Zava, D. T., and W. L. McGuire, Estrogen receptor: unoccupied sites in nuclei of a breast tumor cell line, JBiol Chem 252: 3703, 1977.
20. Rice, R. H., and G. E. Means, Radioactive labeling of proteins in vitro, J Biol Chem 246: 831, 1971.
21. Bray, G. A., A simple efficient scintillator for counting aqueous solutions in a liquid scintillation counter, Anal Biochem 1: 279, 1960.
22. King, R. J. B., and W. I. P. Mainwaring, Estrogens, In Steroid-Cell Interactions, University Park Press, Baltimore, 1974, p. 191.
23. Mirocha, C. J., C. M. Christensen, and G. H. Nelson, F-2 (zearalenone), estrogenic mycotoxin from Fusarium, In Kades, S., A. Ciegler, and S. J. Ajl (eds.), Microbial Toxins. A Comprehensive Treatise, vol. 7, Academic Press, New York, 1971, p. 107.
24. Mirocha, C. J., and C. M. Christensen, Oestrogenic mycotoxins synthesized by Fusarium, In Purchase, I. F. H. (ed.), Mycotoxins, Elsevier, New York, 1974, p. 129.
25. Sharp, G. D., and I. A. Dyner, Effect of zearalenol on the performance and carcass composition of growingfinishing ruminants, J Anim Sci 33: 865, 1971.
26. Veno, Y., and S. Yagasaki, Toxicological approaches to the metabolites of Fusaria. X. Accelerating effect of zearalenone on RNA and protein synthesis in the uterus of ovariectomized mice, Jap J Exp Med 45: 199, 1975.
27. Veno, Y., N. Shimada, S. Yagasaki, and M. Enomoto, Toxicological approaches to the metabolites of Fusaria. VII. Effects of zearalenone on the uteri of mice and rats, Chern Pharm Bull 22: 2830, 1974.
28. 2 toxin (zearalenone) on reproduction in female swine, Magy Allatorvosok Lapja 29: 723, 1974.
29. Hobson, W., J. Bailey, and G. B. Fuller, Hormone effects of zearalenone in nonhuman primates, J Toxicol Environ Health 3: 43, 1977.
30. Veno, Y., and K. Kubota, DNA-attaching ability of carcinogenic mycotoxins in recombination deficient mutant cells of Bacillus subtilis, Cancer Res 36: 445, 1976.
31. 2 toxin (zearalenone) in monolayer tissue culture, Magy Allatorvosok Lapja 29: 191, 1974.
32. Ruddick, J. A., P. M. Scott, and J. Harwick, Teratologic evaluation of zearalenone administered orally to the rat, Bull Environ Contam Toxicol 15: 678, 1976.
33. Miller, J. K., A. Hacking, and V. J. Gross, Stillbirths, neonatal mortality and small litters in pigs associated with ingestion of Fusarium toxin by pregnant sows, Vet Rec 93: 555, 1973.
34. Schoental, R., Role of podophyllotoxin in the bedding and dietary zearalenone on incidence of “spontaneous” tumors in laboratory animals, Cancer Res 34: 2419, 1974.
35. Bickoff, E. M., A. L. Livingston, and A. N. Booth, Estrogenic activity of coumestrol and related compounds, Arch Biochem Biophys 88: 262, 1960.
36. Cheng, E., L. Yoder, C. D. Sotry, and W. Burroughs, Estrogenic activity of some isoflavone derivatives, Science 120: 575, 1954.
37. Wong, E., and D. S. Flux, The oestrogenic activity of red clover isoflavones and some of their degradation products, J Endocrinol 24: 341, 1962.
38. Noteboom, W. D., and J. Gorski, Estrogen effect of genistein and coumestrol diacetate, Endocrinology 73: 736, 1963.
39. Lee, Y. J., A. C. Notides, Y. G. Tsay, and A. S. Kende, Coumestrol, NBD-norhexestrol, and dansyl-norhex-estrol; fluorescent probes of estrogen-binding proteins, Biochemistry 16; 2896, 1977.
40. Huggins, C., R. C. Moon, and S. Morri, Extinction of experimental mammary cancer. I. Estradiol 17-β and progesterone, Proc Natl Acad Sci 48: 379, 1962.
41. Meites, J., E. Cassell, and J. Clark, Estrogen inhibition of mammary tumor growth in rats; counteraction by prolactin, Proc Soc Exp Biol Med 137: 1225, 1971.